Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-08 11:29 am Purchase | 2024-12-31 | 13G | TG Therapeutics, Inc. TGTX | The Vanguard Group | 15,596,480 10.010% | 1,925,536 (+14.08%) | Filing History |
| 2024-11-14 7:45 pm Sale | 2024-09-30 | 13G | TG Therapeutics, Inc. TGTX | Darwin Global Management Ltd. | 0 0.000% | -4,046,598 (Position Closed) | Filing History |
| 2024-10-07 4:08 pm Purchase | 2024-09-30 | 13G | TG Therapeutics, Inc. TGTX | BlackRock Inc. BLK | 21,956,312 14.200% | 11,188,149 (+103.90%) | Filing History |
| 2024-02-14 3:30 pm Sale | 2023-12-31 | 13G | TG Therapeutics, Inc. TGTX | Darwin Global Management Ltd. | 4,046,598 2.700% | -6,404,643 (-61.28%) | Filing History |
| 2024-02-13 5:15 pm Sale | 2023-12-29 | 13G | TG Therapeutics, Inc. TGTX | The Vanguard Group | 13,670,944 9.030% | -1,831,820 (-11.82%) | Filing History |
| 2024-01-26 4:23 pm Purchase | 2023-12-31 | 13G | TG Therapeutics, Inc. TGTX | BlackRock Inc. BLK | 10,768,163 7.100% | 1,635,273 (+17.91%) | Filing History |
| 2024-01-25 11:29 am Sale | 2023-12-31 | 13G | TG Therapeutics, Inc. TGTX | STATE STREET CORP STT | 8,253,573 5.450% | -2,161,588 (-20.75%) | Filing History |
| 2023-04-03 08:00 am Purchase | 2023-03-22 | 13G | TG Therapeutics, Inc. TGTX | Darwin Global Management Ltd. | 10,451,241 7.100% | 10,451,241 (New Position) | Filing History |
| 2023-02-09 12:39 pm Sale | 2023-02-09 | 13G | TG Therapeutics, Inc. TGTX | FMR LLC | 7,188,862 4.946% | -865,599 (-10.75%) | Filing History |
| 2023-02-09 11:35 am Purchase | 2022-12-30 | 13G | TG Therapeutics, Inc. TGTX | The Vanguard Group | 15,502,764 10.670% | 756,372 (+5.13%) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | TG Therapeutics, Inc. TGTX | STATE STREET CORP STT | 10,415,161 7.170% | 7,009,856 (+205.85%) | Filing History |
| 2023-02-01 4:54 pm Purchase | 2022-12-31 | 13G | TG Therapeutics, Inc. TGTX | BlackRock Inc. BLK | 9,132,890 6.300% | 230,725 (+2.59%) | Filing History |
| 2022-10-11 10:07 am Purchase | 2022-09-30 | 13G | TG Therapeutics, Inc. TGTX | The Vanguard Group | 14,746,392 10.150% | 2,654,955 (+21.96%) | Filing History |
| 2022-07-11 08:49 am Sale | 2022-07-08 | 13G | TG Therapeutics, Inc. TGTX | FMR LLC | 8,054,461 5.576% | -12,666,970 (-61.13%) | Filing History |
| 2022-02-10 08:42 am Purchase | 2021-12-31 | 13G | TG Therapeutics, Inc. TGTX | The Vanguard Group | 12,091,437 8.460% | 1,120,574 (+10.21%) | Filing History |
| 2022-02-09 10:01 am Purchase | 2022-02-08 | 13G | TG Therapeutics, Inc. TGTX | FMR LLC | 20,721,431 14.496% | 5,894,295 (+39.75%) | Filing History |
| 2022-02-01 5:08 pm Purchase | 2021-12-31 | 13G | TG Therapeutics, Inc. TGTX | BlackRock Inc. BLK | 8,902,165 6.200% | 345,879 (+4.04%) | Filing History |
| 2021-02-16 4:13 pm Sale | 2020-12-31 | 13G | TG Therapeutics, Inc. TGTX | GREAT POINT PARTNERS LLC | 0 0.000% | -5,434,783 (Position Closed) | Filing History |
| 2021-02-10 4:49 pm Sale | 2021-01-31 | 13G | TG Therapeutics, Inc. TGTX | RA CAPITAL MANAGEMENT L.P. | 6,361,123 4.700% | -2,324,348 (-26.76%) | Filing History |
| 2021-02-10 4:34 pm Sale | 2020-12-31 | 13G | TG Therapeutics, Inc. TGTX | RA CAPITAL MANAGEMENT L.P. | 8,685,471 6.400% | -4,102,986 (-32.08%) | Filing History |